Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Dig Dis Sci. 2011 Feb;56(2):586-90. doi: 10.1007/s10620-010-1304-4. Epub 2010 Jun 29.
Pancreatobiliary disease is increased in elderly patients. Because of significant comorbidities, these patients may be at greater risk of developing complications related to endoscopic retrograde cholangiopantreatography (ERCP).
The purpose of this study was to compare the indications, interventions, and complications of ERCP of octogenarians with nonoctogenarians.
A retrospective review of patient records from a single tertiary care hospital was performed. Adult patients undergoing ERCP were divided into two groups according to age. Group 1 patients were of age < 80 years (N = 391), and group 2 patients were > 80 years of age (N = 102). Indications, therapeutic interventions, use of conscious sedation, duration of procedure and complications were retrieved from the patient records. Main outcome measurements included: indications, therapeutic interventions, use of conscious sedation, duration of procedure and complications.
There was an increase in sphincterotomy rates (74 vs 63%; P < 0.05) and stent insertions (48 vs 29%; P < 0.001) in the octogenarian group. In group 1 there were 19 cases (4.9%) of post ERCP pancreatitis who spent 251 hospital days (including 59 ICU days) compared with one case (0.98%) in group 2 who required ten hospital days (P < 0.05) and 0 ICU days. Procedure time for octogenarians was greater than nonoctogenarians (33.1 vs 29.8 min; P < 0.05). Octogenarians required less conscious sedation than nonoctogenarians (midazolam 4.1 vs 5.9 mg; P < 0.05 and fentanyl 45.5 vs 80.4 mcg; P < 0.05).
In octogenarians, ERCP is efficacious and safe. It is associated with a lower rate of hospitalization for pancreatitis. ERCP in octogenarians takes longer, is associated with increased interventions (stent insertion and sphincterotomy) and requires less sedation.
老年患者的胰胆疾病发病率增加。由于存在显著的合并症,这些患者可能面临与内镜逆行胰胆管造影术(ERCP)相关的并发症的风险更高。
本研究旨在比较 80 岁以上和 80 岁以下患者行 ERCP 的适应证、干预措施和并发症。
对一家三级保健医院的患者病历进行回顾性分析。根据年龄将接受 ERCP 的成年患者分为两组。第 1 组患者年龄<80 岁(N=391),第 2 组患者年龄>80 岁(N=102)。从病历中检索适应证、治疗性干预、清醒镇静的使用、操作时间和并发症等信息。主要观察指标包括:适应证、治疗性干预、清醒镇静的使用、操作时间和并发症。
80 岁以上患者行括约肌切开术的比例(74%比 63%;P<0.05)和支架置入术的比例(48%比 29%;P<0.001)均增加。第 1 组中有 19 例(4.9%)患者发生 ERCP 后胰腺炎,住院 251 天(包括 59 天 ICU 住院),而第 2 组中仅有 1 例(0.98%)患者发生胰腺炎,住院 10 天(P<0.05),无 ICU 住院。80 岁以上患者的操作时间长于 80 岁以下患者(33.1 分钟比 29.8 分钟;P<0.05)。80 岁以上患者清醒镇静药物的使用剂量小于 80 岁以下患者(咪达唑仑 4.1 毫克比 5.9 毫克;P<0.05,芬太尼 45.5 微克比 80.4 微克;P<0.05)。
80 岁以上患者行 ERCP 安全有效。ERCP 后胰腺炎的住院率较低。80 岁以上患者行 ERCP 操作时间较长,干预措施(支架置入术和括约肌切开术)更多,镇静药物使用剂量更小。